Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease

Diabetes Care

Volumn 37, Issue 2, 2014, Pages 389-395

  Kinney, Gregory L ^a   Black Shinn, Jennifer L ^a   Wan, Emily S ^b   Make, Barry ^c   Regan, Elizabeth ^c   Lutz, Sharon ^a   Soler, Xavier ^d   Silverman, Edwin K ^b   Crapo, James ^a   Hokanson, John E ^a  

^a Global Health and Health Disparities   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; INSULIN; METFORMIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISPANIC; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CASE CONTROL STUDY; COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; LUNG; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; VITAL CAPACITY;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; VITAL CAPACITY;

EID: 84893028484     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1435     Document Type: Article

References (31)

1. Sandler M. Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med 1990; 150:1385-1388
2. Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol 2012;11:132
3. Sandler M, Bunn AE, Stewart RI. Crosssection study of pulmonary function in patients with insulin-dependent diabetesmellitus. Am Rev Respir Dis 1987;135:223- 229
4. Klein OL, Meltzer D, Carnethon M, Krishnan JA. Type II diabetes mellitus is associated with decreased measures of lung function in a clinical setting. Respir Med 2011;105: 1095-1098
5. van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest 2010;138:393-406
6. Kaparianos A, Argyropoulou E, Sampsonas F, Karkoulias K, Tsiamita M, Spiropoulos K. Pulmonary complications in diabetes mellitus. Chron Respir Dis 2008;5:101-108
7. Dieterle CD, Schmauss S, Arbogast H, Domsch C, Huber RM, Landgraf R. Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation.Transplantation 2007;83:566-569
8. Yeh HC, Punjabi NM, Wang NY, et al. Crosssectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008;31:741-746
9. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002; 20:1406-1412
10. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J1998;12:641-645
11. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93:137-188
12. Vracko R. Effects of aging and diabetes on basal lamina thickness of six cell types. In Biology and Chemistry of Basement Membranes. New York, Academic Press, Inc., 1978, p. 483-493
13. Yesil Y, Ugur-Altun B, Turgut N, et al. Phrenic neuropathy in diabetic and prediabetic patients withoutneuromuscular complaint. Acta Diabetol.28 January 2012 [Epub ahead f print]
14. Brannagan TH, Promisloff RA, McCluskey LF, Mitz KA. Proximal diabetic neuropathy presenting with respiratoryweakness. JNeurol Neurosurg Psychiatry 1999;67:539-541
15. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-289
16. Kalsi KK, Baker EH, Fraser O, et al. Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism. Pflugers Arch 2009;457:1061-1070
17. Baker EH, Bell D. Blood glucose: of emerging importance in COPD exacerbations. Thorax 2009;64:830-832
18. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43
19. Miller MR, Crapo R, Hankinson J, et al.; ATS/ ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26:153-161
20. Jones PSt. George's Respiratory Questionnaire Manual. Version 2.3. London, St. George's, University of London, 2009
21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117
22. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179- 187
23. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, Georgia, U.S. Department of Health and Human Services, Centers forDisease Control and Prevention, 2011
24. Fehrenbach H, Kasper M, Tschernig T, Shearman MS, Schuh D, Muller M. Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular andsubcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) 1998; 44:1147-1157
25. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide ssociation studies identify multiple loci associated with pulmonary function. Nat Genet 2010; 42:45- 52
26. Bauer TA, Reusch JE, Levi M, Regensteiner JG. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics intype 2 diabetes. Diabetes Care 2007;30: 2880-2885
27. Regensteiner JG, Bauer TA, Reusch JE, et al. Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Med Sci Sports Exerc 2009;41:977-984
28. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979;120:973-983
29. Tang EW, Jardine DL, Rodins K, Evans J. Respiratory failure secondary to diabetic neuropathy affecting the phrenic nerve. Diabet Med 2003;20:599-601
30. Spruit MA, Polkey MI, Celli B, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012;13: 291-297
31. Polkey MI, Spruit MA, Edwards LD, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Sixminute- walk test in chronic obstructivepulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med2013;187:382-386